Veraxa Biotech Holding AG (VRXAW) Retained Earnings (2024 - 2025)
Veraxa Biotech Holding AG (VRXAW) posted quarterly Retained Earnings of -$33601.4 for Q4 2025, up 99.91% year-over-year from -$16808.5 in Q4 2024, and up 99.91% quarter-over-quarter from -$36.4 million in Q4 2024.
Veraxa Biotech Holding AG (VRXAW) Retained Earnings (2024 - 2025) Analysis & Trends
Veraxa Biotech Holding AG (VRXAW) has reported Retained Earnings for 2 consecutive years, with -$33601.4 the latest figure, recorded in Q4 2025.
- In Q4 2025, Retained Earnings rose 99.91% year-over-year to -$33601.4; the TTM figure through Dec 2025 stood at -$33601.4 (up 99.91% YoY), while the FY2025 annual figure was -$33601.4, up 99.91% from the prior year.
- Retained Earnings improved to -$33601.4 in Q4 2025 per VRXAW's latest filing, from -$36.4 million in the prior quarter.
- Across five years, Retained Earnings topped out at -$33601.4 in Q4 2025 and bottomed at -$36.4 million in Q4 2024.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -33,601.42 |
| Dec 31, 2024 | -36.37 Mn |